Literature DB >> 3547088

Primary structure polymorphism at amino acid residue 72 of human p53.

G J Matlashewski, S Tuck, D Pim, P Lamb, J Schneider, L V Crawford.   

Abstract

We analyzed p53 cDNA and genomic clones from a variety of normal and transformed cells. Sequence analysis of these clones revealed that amino acid residue 72 can be an arginine, proline, or cysteine. This single codon difference results in electrophoretically distinct forms of human p53 seen in normal and transformed cells.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3547088      PMCID： PMC365159          DOI： 10.1128/mcb.7.2.961-963.1987

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN： 0270-7306            Impact factor:   4.272


  16 in total

1.  Characterization of the human p53 gene.

Authors:  P Lamb; L Crawford
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

2.  Participation of p53 cellular tumour antigen in transformation of normal embryonic cells.

Authors:  D Eliyahu; A Raz; P Gruss; D Givol; M Oren
Journal:  Nature       Date:  1984 Dec 13-19       Impact factor: 49.962

Review 3.  The 53,000-dalton cellular protein and its role in transformation.

Authors:  L Crawford
Journal:  Int Rev Exp Pathol       Date:  1983

4.  Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53.

Authors:  J R Jenkins; K Rudge; G A Currie
Journal:  Nature       Date:  1984 Dec 13-19       Impact factor: 49.962

5.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

6.  Characterization of human p53 antigens employing primate specific monoclonal antibodies.

Authors:  R Thomas; L Kaplan; N Reich; D P Lane; A J Levine
Journal:  Virology       Date:  1983-12       Impact factor: 3.616

7.  A cDNA cloning vector that permits expression of cDNA inserts in mammalian cells.

Authors:  H Okayama; P Berg
Journal:  Mol Cell Biol       Date:  1983-02       Impact factor: 4.272

8.  Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation.

Authors:  L F Parada; H Land; R A Weinberg; D Wolf; V Rotter
Journal:  Nature       Date:  1984 Dec 13-19       Impact factor: 49.962

9.  Isolation and characterization of a human p53 cDNA clone: expression of the human p53 gene.

Authors:  G Matlashewski; P Lamb; D Pim; J Peacock; L Crawford; S Benchimol
Journal:  EMBO J       Date:  1984-12-20       Impact factor: 11.598

10.  Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells.

Authors:  R Zakut-Houri; B Bienz-Tadmor; D Givol; M Oren
Journal:  EMBO J       Date:  1985-05       Impact factor: 11.598
View more
  128 in total

1.  DNA sequence variants of p53: cancer and aging.

Authors:  Y Sun; C Keshava; D S Sharp; A Weston; E C McCanlies
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

2.  Functional analysis of the p53 codon 72 polymorphism in black South Africans with rheumatoid arthritis--a pilot study.

Authors:  Devapregasan Moodley; Girish M Mody; Anil A Chuturgoon
Journal:  Clin Rheumatol       Date:  2010-06-10       Impact factor: 2.980

3.  Meta-analysis shows significant association of the TP53 Arg72Pro with ovarian cancer risk.

Authors:  Su-Qin Shen; De-Ke Jiang; Guo-Yuan Liu; Fang Chen; Long Yu
Journal:  Mol Biol Rep       Date:  2011-09-28       Impact factor: 2.316

4.  TP53 Arg72Pro polymorphism and endometrial cancer risk: a meta-analysis.

Authors:  De-Ke Jiang; Lei Yao; Wei-Hua Ren; Wen-Zhang Wang; Bo Peng; Long Yu
Journal:  Med Oncol       Date:  2010-06-15       Impact factor: 3.064

5.  Characterization of the human p53 gene promoter.

Authors:  S P Tuck; L Crawford
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

6.  TP53 codon 72 polymorphism in 12 populations of insular Southeast Asia and Oceania.

Authors:  Taeko Kashima; Kumiko Makino; Augustinua Soemantri; Takafumi Ishida
Journal:  J Hum Genet       Date:  2007-07-03       Impact factor: 3.172

7.  The expression of biologically active human p53 in Leishmania cells: a novel eukaryotic system to produce recombinant proteins.

Authors:  W W Zhang; H Charest; G Matlashewski
Journal:  Nucleic Acids Res       Date:  1995-10-25       Impact factor: 16.971

8.  A functional SNP in the MDM2 promoter, pigmentary phenotypes, and risk of skin cancer.

Authors:  Hongmei Nan; Abrar A Qureshi; David J Hunter; Jiali Han
Journal:  Cancer Causes Control       Date:  2008-09-24       Impact factor: 2.506

9.  p53 codon 72 polymorphism and risk of cervical carcinoma in Moroccan women.

Authors:  M Meftah El khair; M M Ennaji; R El kebbaj; R Ait Mhand; M Attaleb; M El Mzibri
Journal:  Med Oncol       Date:  2009-09-23       Impact factor: 3.064

10.  Analysis of functional germline polymorphisms for prediction of response to anthracycline-based neoadjuvant chemotherapy in breast cancer.

Authors:  Joanna Szkandera; Gudrun Absenger; Nadia Dandachi; Peter Regitnig; Sigurd Lax; Michael Stotz; Hellmut Samonigg; Wilfried Renner; Armin Gerger
Journal:  Mol Genet Genomics       Date:  2012-08-18       Impact factor: 3.291
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.